Abnormal amyloid β42 expression and increased oxidative stress in plasma of CKD patients with cognitive dysfunction: A small scale case control study comparison with Alzheimer's disease

Cognitive dysfunction has been increasingly recognized in chronic kidney disease (CKD) patients. Senile plaques are important pathophysiological characteristic of cognitive dysfunction. The major component of plaques is the amyloid β (Aβ) peptide released from proteolytic cleavage of amyloid precurs...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	BBA clinical 2017-12, Vol.8, p.20-27
Hauptverfasser:	Vinothkumar, G., Kedharnath, C., Krishnakumar, S., Sreedhar, S., Preethikrishnan, K., Dinesh, S., Sundaram, A., Balakrishnan, D., Shivashekar, G., Sureshkumar, Venkataraman, P.
Format:	Artikel
Sprache:	eng
Schlagworte:	Amyloid β APP processing Chronic kidney disease Cognitive dysfunction Oxidative stress Regular
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!